September 8, 2021
Catabasis Takes New Name to Highlight New Focus
Read More
July 13, 2021
Poxel Shifts Focus to Rare Metabolic Diseases
Read More
June 29, 2021
Orphazyme Lays Off Two-Thirds of Staff After FDA Setback
Read More
June 14, 2021
CDMO Yposkesi Launches Construction of Advanced Therapy Facility Near Paris
Read More
June 3, 2021
Auris Medical Reboots to RNA Therapeutics with Acquisition of Trasir Therapeutics
Read More
April 7, 2021
Ionis Signs Distribution Deal with Sobi and Cuts 70 Percent of Akcea Workforce
Read More
April 1, 2021
Nitto to Invest $226 Million to Expand Oligonucleotide Manufacturing in Massachusetts
Read More
March 22, 2021
VeriSIM Launches PulmoSIM to Develop Treatments for Rare Respiratory Diseases
Read More
March 4, 2021
Biogen Will Construct $200 Million Gene Therapy Manufacturing Facility in North Carolina
Read More
February 11, 2021
Chinook Tackles Rare Chronic Kidney Diseases
Read More
January 13, 2021
Taysha and UT Southwestern Launch Innovation Fund to Advance CNS Gene Therapies into Clinic
Read More
January 11, 2021
Bluebird Bio Retains Gene Therapy and Spins Out Oncology into Separate Company
Read More
Load More
X